GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $394,000 | -87.2% | 4,500 | -84.7% | 0.01% | -75.0% |
Q4 2019 | $3,067,000 | +1084.2% | 29,332 | +1203.1% | 0.02% | +1100.0% |
Q3 2019 | $259,000 | -65.0% | 2,251 | -47.7% | 0.00% | -71.4% |
Q2 2019 | $741,000 | +51.5% | 4,300 | +48.3% | 0.01% | +40.0% |
Q1 2019 | $489,000 | -52.2% | 2,900 | -72.4% | 0.01% | -44.4% |
Q4 2018 | $1,023,000 | -84.1% | 10,500 | -71.9% | 0.01% | -74.3% |
Q3 2018 | $6,451,000 | +152.2% | 37,351 | +103.8% | 0.04% | +169.2% |
Q2 2018 | $2,558,000 | -63.4% | 18,328 | -65.4% | 0.01% | -65.8% |
Q4 2017 | $6,988,000 | +192.0% | 52,936 | +124.5% | 0.04% | +123.5% |
Q3 2017 | $2,393,000 | +816.9% | 23,582 | +807.0% | 0.02% | +750.0% |
Q2 2017 | $261,000 | -23.0% | 2,600 | -7.1% | 0.00% | -33.3% |
Q1 2017 | $339,000 | -98.2% | 2,800 | -98.3% | 0.00% | -98.1% |
Q4 2016 | $18,684,000 | +274.0% | 167,191 | +344.2% | 0.16% | +250.0% |
Q3 2016 | $4,996,000 | +1851.6% | 37,641 | +960.3% | 0.05% | +2200.0% |
Q1 2016 | $256,000 | – | 3,550 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |